Schedule 13G ownership disclosure
Protalix BioTherapeutics, Inc.
Security class unavailable · CUSIP: 74365A101
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.1200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001546927-16-000412
- Form type
- SC 13G
- Filer
- Opaleye Management Inc.
- CIK
- CIK 1595855
- Filed
- Feb 12, 2016
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership